Novel nanomedicines to overcome cancer multidrug resistance

Z Su, S Dong, SC Zhao, K Liu, Y Tan, X Jiang… - Drug Resistance …, 2021 - Elsevier
Chemotherapy remains a powerful tool to eliminate malignant cells. However, the efficacy of
chemotherapy is compromised by the frequent emergence of intrinsic and acquired …

Recent progress in functionalized and targeted polymersomes and chimeric polymeric nanotheranostic platforms for cancer therapy

M Beygi, F Oroojalian, SS Hosseini… - Progress in Materials …, 2023 - Elsevier
The majority of advances in cancer therapy have been achieved based on developments in
public awareness, as well as novel diagnostic and therapeutic modalities. Treatment …

Poly (disulfide) s: from synthesis to drug delivery

R Zhang, T Nie, Y Fang, H Huang, J Wu - Biomacromolecules, 2021 - ACS Publications
Bioresponsive polymers have been widely used in drug delivery because of their
degradability. For example, poly (disulfide) s with repeating disulfide bonds in the main …

Ultrasound nanotheranostics: Toward precision medicine

Y Qin, X Geng, Y Sun, Y Zhao, W Chai, X Wang… - Journal of Controlled …, 2023 - Elsevier
Ultrasound (US) is a mechanical wave that can penetrate biological tissues and trigger
complex bioeffects. The mechanisms of US in different diagnosis and treatment are different …

Emerging era of “somes”: Polymersomes as versatile drug delivery carrier for cancer diagnostics and therapy

AK Sharma, P Prasher, AA Aljabali, V Mishra… - Drug delivery and …, 2020 - Springer
Over the past two decades, polymersomes have been widely investigated for the delivery of
diagnostic and therapeutic agents in cancer therapy. Polymersomes are stable polymeric …

Polymersome Membrane Engineering with Active Targeting or Controlled Permeability for Responsive Drug Delivery

A Kayani, A Raza, J Si, D Dutta, Q Zhou… - Biomacromolecules, 2023 - ACS Publications
Polymersomes have been extensively investigated for drug delivery as nanocarriers for two
decades due to a series of advantages including high stability under physiological …

Nanomedicine in cancer therapy

D Fan, Y Cao, M Cao, Y Wang, Y Cao… - Signal Transduction and …, 2023 - nature.com
Cancer remains a highly lethal disease in the world. Currently, either conventional cancer
therapies or modern immunotherapies are non-tumor-targeted therapeutic approaches that …

Margetuximab conjugated-PEG-PAMAM G4 nano-complex: a smart nano-device for suppression of breast cancer

Y Khakinahad, S Sohrabi, S Razi, A Narmani… - Biomedical Engineering …, 2022 - Springer
Breast cancer due to its high incidence and mortality is the second leading cause of death
among females. On the other hand, nanoparticle-based drug delivery is one of the most …

Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91

M Hanafi, X Chen, N Neamati - Journal of medicinal chemistry, 2021 - ACS Publications
Napabucasin, undergoing multiple clinical trials, was reported to inhibit the signal
transducer and transcription factor 3 (STAT3). To better elucidate its mechanism of action …

Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors

B Mamnoon, J Loganathan, MI Confeld… - ACS applied bio …, 2020 - ACS Publications
High recurrence and metastasis to vital organs are the major characteristics of triple-
negative breast cancer (TNBC). Low vascular oxygen tension promotes resistance to chemo …